Growth Metrics

Odyssey Health (ODYY) Change in Receivables (2014 - 2024)

Odyssey Health's quarterly Change in Receivables came in at -$268411.0 in Q1 2024, down 1954.95% quarter-over-quarter from $14470.0 in Q4 2023.

Odyssey Health has reported Change in Receivables for 6 years, with the latest figure at -$268411.0 in Q1 2024.

  • For the quarter ending Q1 2024, Change in Receivables changed N/A year-over-year to -$268411.0; the trailing twelve-month figure through Oct 2024 stood at -$268411.0 (down 1954.95% YoY), and the FY2024 full-year result was -$253941.0, down 182.45% from the prior year.
  • Change in Receivables for Q1 2024 stood at -$268411.0, down from $14470.0 in the prior quarter.
  • The five-year high for Change in Receivables was $14470.0 in Q4 2023, with the low at -$268411.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 42.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -444.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -13.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 117.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 117.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -124.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -141.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.50 Mn
10 Odyssey Health - - - -

Historic Data

Download Data 🔒
DateValue
Jan 31, 2024 -268,411.00
Jan 31, 2024 -268,411.00
Oct 31, 2023 14,470.00
Oct 31, 2023 14,470.00
Jan 31, 2017 -10,000.00
Jan 31, 2017 -10,000.00
Oct 31, 2016 -7,000.00
Oct 31, 2016 -7,000.00
Jul 31, 2016 -4,448.00
Jul 31, 2016 -4,448.00
Apr 30, 2016 22,500.00
Apr 30, 2016 22,500.00
Apr 30, 2015 -47,151.00
Apr 30, 2015 -47,151.00
Jan 31, 2015 30,231.00
Jan 31, 2015 30,231.00
Oct 31, 2014 16,920.00
Oct 31, 2014 16,920.00